Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.320
-0.060 (-2.52%)
At close: Nov 13, 2026, 4:00 PM EST
2.250
-0.070 (-3.02%)
After-hours: Nov 13, 2026, 7:58 PM EST
Nautilus Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 10.47 | 12.39 | 27.65 | 19.4 | 114.52 | 185.62 |
Short-Term Investments | 76.11 | 91.02 | 102.25 | 154.02 | 69.95 | 160.11 |
Cash & Short-Term Investments | 86.58 | 103.41 | 129.89 | 173.42 | 184.47 | 345.73 |
Cash Growth | -34.13% | -20.39% | -25.10% | -5.99% | -46.64% | 350.51% |
Prepaid Expenses | 2.76 | 2.56 | 2.93 | 3.42 | 2.74 | 3.49 |
Total Current Assets | 90.24 | 105.96 | 132.83 | 176.84 | 187.21 | 349.22 |
Property, Plant & Equipment | 29.86 | 31.23 | 32.33 | 36.9 | 32.57 | 31.86 |
Long-Term Investments | 27.77 | 52.74 | 76.41 | 90.65 | 129.17 | 16.37 |
Other Long-Term Assets | 1.06 | 1.18 | 1.18 | 1.18 | 1.11 | 1 |
Total Assets | 148.92 | 191.11 | 242.74 | 305.57 | 350.05 | 398.45 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.27 | 0.94 | 0.99 | 1.64 | 1.27 | 1.72 |
Accrued Expenses | 3.46 | 2.99 | 2.03 | 3.57 | 3.09 | 2.73 |
Current Portion of Leases | 4.13 | 3.83 | 4.1 | 3.54 | 1.99 | 0.97 |
Other Current Liabilities | 0.48 | 0.18 | 0.52 | 0.38 | 0.44 | 0.39 |
Total Current Liabilities | 9.76 | 7.95 | 7.63 | 9.12 | 6.79 | 5.81 |
Long-Term Leases | 22.61 | 26.19 | 26.38 | 31.09 | 28.34 | 29.06 |
Total Liabilities | 32.37 | 34.14 | 34.01 | 40.21 | 35.13 | 34.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 493.94 | 488.74 | 481.68 | 467.83 | 455.33 | 444.39 |
Retained Earnings | -376.82 | -332.02 | -273.02 | -202.24 | -138.56 | -80.64 |
Comprehensive Income & Other | -0.57 | 0.24 | 0.06 | -0.26 | -1.85 | -0.18 |
Total Common Equity | 116.56 | 156.97 | 208.73 | 265.35 | 314.92 | 363.58 |
Shareholders' Equity | 116.56 | 156.97 | 208.73 | 265.35 | 314.92 | 363.58 |
Total Liabilities & Equity | 148.92 | 191.11 | 242.74 | 305.57 | 350.05 | 398.45 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 26.74 | 30.02 | 30.48 | 34.63 | 30.33 | 30.03 |
Net Cash (Debt) | 59.84 | 73.39 | 99.42 | 138.79 | 154.14 | 315.7 |
Net Cash Growth | -42.70% | -26.18% | -28.37% | -9.96% | -51.17% | 338.67% |
Net Cash Per Share | 0.47 | 0.58 | 0.79 | 1.11 | 1.24 | 3.74 |
Filing Date Shares Outstanding | 127.37 | 126.56 | 126.15 | 125.1 | 124.87 | 124.43 |
Total Common Shares Outstanding | 127.33 | 126.47 | 126.11 | 125.07 | 124.87 | 124.3 |
Working Capital | 80.48 | 98.01 | 125.19 | 167.72 | 180.42 | 343.41 |
Book Value Per Share | 0.92 | 1.24 | 1.66 | 2.12 | 2.52 | 2.92 |
Tangible Book Value | 116.56 | 156.97 | 208.73 | 265.35 | 314.92 | 363.58 |
Tangible Book Value Per Share | 0.92 | 1.24 | 1.66 | 2.12 | 2.52 | 2.92 |
Machinery | 10.07 | 9.65 | 9.31 | 7.88 | 5.42 | 4.19 |
Construction In Progress | 4.02 | 1.81 | 1.19 | 0.9 | 1.24 | 0.28 |
Leasehold Improvements | 0.06 | 0.12 | 0.12 | 0.12 | 0.01 | 0.01 |